Skip to main content

Notable Upgrades: Kite Pharma, Inc. (KITE), Harley-Davidson (HOG), Juniper (JNPR), Supernus (SUPN), Alaska Air (ALK)

In a report published Thursday, Maxim Group analysts initiated coverage on Kite Pharma, Inc. (KITE) with a ‘Buy‘ rating and $87 price target. On valuation measures, Kite Pharma Inc. shares currently have t-12 price/sales of 881.36 while EPS is ($1.72). Currently there are 8 analysts that rate KITE a ‘Buy’ versus zero rating it a […] View the full post at: Notable Upgrades: Kite Pharma, Inc. (KITE), Harley-Davidson (HOG), Juniper (JNPR), Supernus (SUPN), Alaska Air (ALK) Related posts: Harley Davidson: First Loss in 16 Years Harley’s Valuation Looks Too Rich Pharma Megamergers: Will They Continue?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.